New directions in the prognostic evaluation of non-Hodgkin's lymphoma
Gobbi, M.; Pileri, S.; Testoni, N.; Mazza, P.; Dinota, A.; Tura, S.
Haematologica 74(5 Suppl): 392-402
1989
ISSN/ISBN: 0390-6078 PMID: 2512223 Document Number: 335790
Document emailed within 1 workday
Related Documents
Gao, Y.; Li, Y.; Yuan, Z.; Zhao, L.; Liu, X.; Gu, D.; Qian, T.; Yu, Z. 2002: Prognostic factors in patients with primary non-Hodgkin's lymphoma of the tonsil Zhonghua Zhong Liu Za Zhi 24(5): 483-485Takenaka, T.; Kimura, K.; Konda, C.; Sakano, T.; Shimoyama, M.; Kitahara, T.; Minato, K. 1983: Clinical studies of leukemic non-Hodgkin's lymphoma. II. Clinicopathological aspects and prognostic factors Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 46(6): 1256-1265
Vassilakopoulos, T.P.; Nadali, G.; Angelopoulou, M.K.; Siakantaris, M.P.; Dimopoulou, M.N.; Kontopidou, F.N.; Rassidakis, G.Z.; Doussis-Anagnostopoulou, I.A.; Hatzioannou, M.; Vaiopoulos, G.; Kittas, C.; Sarris, A.H.; Pizzolo, G.; Pangalis, G.A. 2001: Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma Haematologica 86(3): 274-281
Bremnes, R.M.; Vik, A.; Helbekkmo, N. 1998: Low-grade non-Hodgkin's lymphoma in northern Norway: treatment, outcome, and prognostic factors Anticancer Research 18(3b): 1921-1929
Iyer, V.K.; Raina, V.; Dawar, R. 2000: Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin's lymphoma Indian Journal of Cancer 37(4): 140-147
Dura, W.T.; Wichrzycka, E.; Woźniewicz, B.; Gładkowska-Dura, M.; Cieślak, H. 1979: Non-Hodgkin lymphoma in developmental age (morphological analysis and prognostic factors based on the Kiel classification) Patologia Polska 30(3): 329-360
Stolzenbach, G.; Garbrecht, M.; Müllerleile, U. 1978: Intermittent chlorambucil-prednisone therapy in low malignancy non-Hodgkin lymphoma and cyclic induction chemotherapy with COP-bleomycin of severe non-Hodgkin lymphoma according to the Kiel classification Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 177-180
Vassilakopoulos, T.P.; Nadali, G.; Angelopoulou, M.K.; Dimopoulou, M.N.; Siakantaris, M.P.; Kontopidou, F.N.; Karkantaris, C.; Kokoris, S.I.; Dimitriadou, E.M.; Calpadaki, C.; Sarantopoulos, A.; Galani, Z.; Sachanas, S.; Kyrtsonis, M.C.; Tsaftaridis, P.; Variamis, E.; Panayotidis, P.; Pizzolo, G.; Sarris, A.H.; Pangalis, G.A. 2005: Beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimens Journal of BUON: Official Journal of the Balkan Union of Oncology 10(1): 59-69
Gómez Arbonés, X.; Campo Güerri, E.; Virgili, J.M.; Panades Siurana, M.J. 1995: Diagnostic and prognostic value of the immunohistochemical study of proliferating cell nuclear antigen (PCNA) expression in paraffin sections from non-hodgkin's lymphoma Sangre 40(6): 520-521
De Kreuk, M.; Ossenkoppele, G.J.; Meijer, C.J.; Huijgens, P.C. 1996: Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation Bone Marrow Transplantation 17(6): 963-971
Georgiadi, E.C.; Sachinis, N.; Dimtsas, G.; Vassilakopoulos, T.P.; Kittas, C.; Doussis-Anagnostopoulou, I.A. 2012: Evaluation of apoptosis in classical Hodgkin's lymphoma comparing different methods Journal of BUON: Official Journal of the Balkan Union of Oncology 17(4): 746-752
Conde, E.; Sierra, J.; Iriondo, A.; Domingo, A.; García Laraña, J.; Marín, J.; Caballero, D.; Martínez, F.; León, A.; García-Conde, J. 1994: Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO Bone Marrow Transplantation 14(2): 279-286
Reinis, M. 2007: Drug evaluation: FavId, a patient-specific idiotypic vaccine for non-Hodgkin's lymphoma Current Opinion in Molecular Therapeutics 9(3): 291-298
Ratanatharathorn, V.; Gad-el-Mawla, N.; Wilson, H.E.; Bonnet, J.D.; Rivkin, S.E.; Mass, R. 1982: Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study Cancer Treatment Reports 66(7): 1687-1688
Santini, G.; Coser, P.; Congiu, A.M.; Salvagno, L.; De Souza, C.; Sertoli, M.R.; Olivieri, A.; Chisesi, T.; Rubagotti, A.; Truini, M.; Contu, A.; Porcellini, A.; Zambaldi, G.; Nati, S.; Marino, G.; Rizzoli, V. 2000: VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group Haematologica 85(2): 160-166
Saito, Y.; Kikuchi, Y.; Hayasaka, K.; Amoh, K.; Fujita, M.; Uekita, Y.; Nishino, S. 1989: Effective evaluation of combination chemotherapy in stage I-Ii of non-Hodgkin's lymphoma--a comparison of treatment with multivariate analysis Gan no Rinsho. Japan Journal of Cancer Clinics 35(7): 804-810
Lackowska, B.; Gruchała, A.; Niezabitowski, A.; Radkowski, A.; Skołyszewski, J.; Ryś, J.; Szklarski, W.; Sokołowski, A. 1999: Prognostic and predictive evaluation of DNA content, S-phase fraction and immunophenotyping in non-Hodgkin's lymphomas in adults. A prospective study Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 50(1): 23-29
Montalban, C.; Bellas, C.; Rodriguez-Garcia, J.L.; Aguado, M.; Fernandez-Muñoz, R. 1991: Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient Annals of Oncology: Official Journal of the European Society for Medical Oncology 2(8): 585-587
Hung, I.J.; Yang, C.P. 1989: Evaluation of methotrexate containing chemotherapeutic regimens in the treatment of childhood undifferentiated non-Hodgkin's lymphoma and B cell acute lymphoblastic leukemia Journal of the Formosan Medical Association 88(10): 1016-1022
Rysenga, E.; Linden, M.D.; Carey, J.L.; Ross, C.W.; Schnitzer, B.; Sawdyk, M.; Maeda, K. 1995: Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease Archives of Pathology and Laboratory Medicine 119(1): 88-91